Auto-immune and allergy tests: new sources for diagnostic growth?
Article Abstract:
Auto-immune and allergy research is motivated by the aging baby-boomer generation, as more of this group confronts inflammatory diseases. Understandably, drug company's focus their attention on meeting the needs of this affluent group.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Drug discovery: Bioinformatics: collaloration to develop bio-info software tools
Article Abstract:
Molecular Applications Group and Affymetrix Inc. have entered into anagreement to develop new bioformatics software tools to provide researchers with unprecedented insight into complex genetic data.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Tm Bioscience: Tm Bioscience achieves Affymetrix proof of concept
Article Abstract:
Tm Bioscience has attained proof of concept in their collaboration with Affymetrix. Tm's normalization technology is incorporated in Affymetrix GeneChips for p53-cancer and HIV.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Growth of self-funded plans sets hurdles for state reform efforts. Elections promise greater focus on health care reform Issues
- Abstracts: Industry profile: Low - and high - tech devices for a global market
- Abstracts: Partnership in education: central service prepares students for materiel management duties. Reengineering hospital materiel management
- Abstracts: Just get it right! Measure it and fix it: the only sure route to 98-percent inventory record integrity. Eliminate (don't automate) inventory tracking
- Abstracts: Brand name and generic companies jockey for off-patent business position. Finally, predictable returns on promotional investments